reslizumab - CISMeF

Preferred Label : reslizumab;

MeSH note : humanized anti-IL-5 monoclonal antibody for treatment in patients with nasal polyps;

MeSH hyponym : SCH55700; CEP38072; DCP835; SCH 55700; DCP 835;

Is substance : O;

UNII : 35A26E427H;

Details

Origin ID

C515492;

UMLS CUI

C1869620;

ATC code(s)
- reslizumab [ATC Code]
CISMeF manual mappings
- Reslizumab (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Reslizumab [NCIt concept]
- Reslizumab [SMS substance]
- Reslizumab [ICD-11 Extension code]
- Reslizumab [Anticorps monoclonal]
MeSH indexing information
- Interleukin-5 [MeSH Descriptor]
MeSH term(s) associated for indexing
- antibodies, monoclonal, humanized [MeSH Descriptor]
Pharmacological action(s)
- anti-asthmatic agents [MeSH Descriptor]
Record concept(s)
- CEP-38072 [MeSH concept]
- Cinqair [MeSH concept]
- DCP-835 [MeSH concept]
- SCH-55700 [MeSH concept]
- reslizumab [MeSH concept]
See also inter- (CISMeF)
- Product containing reslizumab (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing reslizumab (medicinal product) [SNOMED CT concept]
- Reslizumab [NCIt concept]
- Reslizumab (substance) [SNOMED CT concept]
- reslizumab [ATC Code]
Validated automatic mappings to BTNT
- reslizumab [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients